home / news releases


Stock News Releases and Press Releases OTCMKTS, NASDAQ and NYSE Markets

Now Trending

Company Name:FibroGen Inc
Stock Symbol:FGEN
Market:NASDAQ
Website:fibrogen.com

Menu

FGEN FGEN Quote FGEN Short FGEN News FGEN Articles FGEN Message Board
Get Alerts

News, Short Squeeze, Breakout and More Instantly...

Search News Releases

CPLP - Expected US Company Earnings on Friday, July 26th, 2024

Bogota Financial Corp. (BSBK) is expected to report for Q2 2024 Capital Product Partners L.P. (CPLP) is expected to report $0.17 for Q2 2024 Colgate-Palmolive Company (CL) is expected to report $0.87 for Q2 2024 ARCA biopharma Inc. (ABIO) is expected to report for Q2 2024 Barnes G...

CHTR - Expected US Company Earnings on Friday, July 26th, 2024

Bogota Financial Corp. (BSBK) is expected to report for Q2 2024 Capital Product Partners L.P. (CPLP) is expected to report $0.17 for Q2 2024 Colgate-Palmolive Company (CL) is expected to report $0.87 for Q2 2024 ARCA biopharma Inc. (ABIO) is expected to report for Q2 2024 Barnes G...

BFIN - Expected US Company Earnings on Friday, July 26th, 2024

Bogota Financial Corp. (BSBK) is expected to report for Q2 2024 Capital Product Partners L.P. (CPLP) is expected to report $0.17 for Q2 2024 Colgate-Palmolive Company (CL) is expected to report $0.87 for Q2 2024 ARCA biopharma Inc. (ABIO) is expected to report for Q2 2024 Barnes G...

BCPC - Expected US Company Earnings on Friday, July 26th, 2024

Bogota Financial Corp. (BSBK) is expected to report for Q2 2024 Capital Product Partners L.P. (CPLP) is expected to report $0.17 for Q2 2024 Colgate-Palmolive Company (CL) is expected to report $0.87 for Q2 2024 ARCA biopharma Inc. (ABIO) is expected to report for Q2 2024 Barnes G...

MRK - Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as First-Line Treatment for Patients With Unresectable or Metastatic Urothelial Carcinoma

Opinion granted based on positive overall survival and progression-free survival results from the Phase 3 KEYNOTE-A39 trial Positive opinion marks step forward for a potential new first-line standard of care for the treatment of patients with this disease in Europe Merck (NYSE: ...

IPSEF - Ipsen receives CHMP positive opinions for Iqirvo® (elafibranor) in Primary Biliary Cholangitis and Kayfanda® (odevixibat) in Alagille Syndrome, two rare cholestatic liver diseases

Ipsen receives CHMP positive opinions for Iqirvo ® (elafibranor) in Primary Biliary Cholangitis and Kayfanda ® (odevixibat) in Alagille Syndrome, two rare cholestatic liver diseases CHMP positive opinion for Iqirvo ® (elafibra...

STSS - Penny Stock Trading: How to Use Chart Patterns Effectively

2024-07-26 06:46:00 ET 3 Tips for Using Chart Patterns When Trading Penny Stocks Utilizing chart patterns is an effective strategy for trading penny stocks , offering valuable insights into potential market movements and helping traders make informed decisions. Recognizing and inter...

POAI - Penny Stock Trading: How to Use Chart Patterns Effectively

2024-07-26 06:46:00 ET 3 Tips for Using Chart Patterns When Trading Penny Stocks Utilizing chart patterns is an effective strategy for trading penny stocks , offering valuable insights into potential market movements and helping traders make informed decisions. Recognizing and inter...

SMCI - Why Super Micro Computer Stock Is Plummeting This Week

2024-07-26 06:45:00 ET Super Micro Computer (NASDAQ: SMCI) stock is sinking in this week's trading. The high-performance server specialist's share price was down 12.7% from last week's close heading into this Friday's market opening, according to data from S&P Global Market In...

SAH - Sonic Automotive Schedules Release of Second Quarter 2024 Financial Results

Sonic Automotive, Inc. (“Sonic Automotive” or “Sonic” or the “Company”) ( NYSE:SAH ), one of the nation’s largest automotive retailers, today announced it will release fiscal 2024 second quarter financial results on Monday, August 5, 2024 by ...

Previous 10 Next 10